MedTrace Logo

VR for Symptom Control and Wellbeing

NCT04821466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-21

No results posted yet for this study

Summary

To investigate the effect that a Virtual Reality experience can have on patient symptoms and wellbeing for palliative care and oncology inpatients

Conditions

  • Oncology
  • End Stage Cancer
  • Palliative Care
  • Hematologic Malignancy

Interventions

DEVICE

Virtual Reality Headset to provide a Virtual Reality Experience

Participants will utilise a Virtual Reality experience for distraction therapy via a Virtual reality headset. Participants will wear the Virtual reality headset to be immersed in a multimedia experience.

Sponsors & Collaborators

  • Royal Cornwall Hospitals Trust

    lead OTHER

Principal Investigators

  • Niall O Moon, BMBCh · Doctor

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-14
Primary Completion
2022-09-20
Completion
2022-09-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04821466 on ClinicalTrials.gov